Related Experiment Video
Updated: Jan 13, 2026
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
Neonatal genetic screening in Changsha: a multicenter study and preliminary findings
Jun He1, Jingjing Zhang2, Shuanglin Xiang3
1Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Hunan Normal University.
Background:
Newborn screening (NBS) is a public health service aimed at identifying infants with severe genetic disorders. Genetic testing is now commonly used for secondary or confirmatory testing after a positive result in some NBS programs. Recently, next-generation sequencing (NGS) has emerged as a robust tool that enables large panels of genes to be scanned together rapidly. Rapid advances in NGS emphasize the potential for genomic sequencing to improve NBS programs. Neonatal genetic screening represents a critical advancement within contemporary NBS frameworks, integrating NGS to enhance disease detection sensitivity and specificity.
Materials And Methods:
This study, conducted through multicenter collaboration in Changsha, screened 2019 neonatal samples for 75 common genetic disorders involving 135 pathogenic genes. The aim was to explore the incidence and mutation spectrum of these disorders in the Chinese population and to propose an optimized screening model.
Results:
The results showed a positive detection rate of 0.74% and a carrier rate of 31.50%.
Conclusion:
This study provides valuable data for refining neonatal genetic screening protocols in China.
